Research News

10335229
MELBOURNE, Australia - -- Avion Medical Skin Centres (AMSC) have entered into an agreement with OncoBeta® GmbH to treat non-melanoma skin cancer (NMSC) patients in Australia, with the new, non-invasive [1] [2] Rhenium-SCT®. The first AMSC location...
10333550
PERTH, Australia - -- OncoBeta® GmbH today announced Perth's Hollywood Private Hospital in Australia is the latest medical facility to participate in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the...
10329376
In its third year, the HR Tech Awards program highlights HR technology companies that serve employers and employees across the globe.
10325657
Track record and unique specialty in IP investigations poises company for exponential growth in 2022
10323647
MUNICH & SYDNEY - -- OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the treatment of non...
10322374
Patent issuance strengthens IP position with regards to novel and environmentally friendly methods of developing blockchain-backed digital assets and applications